Why the study?
Hypertrophic cardiomyopathy is a common inherited heart disease typically caused by mutations in sarcomere or sarcomere-associated proteins, warranting disease modeling tools.
Population
Peripheral blood mononuclear cells from 3 HCM patients carrying TNNI3 mutations
Design
In vitro stem cell line generation and characterization study
Authors
Loading...
iPSC lines from TNNI3-mutant HCM patients enable in vitro modeling; leaves open mechanistic or therapeutic advances pending further validation.
The successful generation of iPSC lines from HCM patients with TNNI3 mutations provides a validated in vitro model for studying hypertrophic cardiomyopathy.
Cao et al. (2021) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: